Innate Pharma Management
Management criteria checks 3/4
Innate Pharma's CEO is Mondher Mahjoubi, appointed in Dec 2016, has a tenure of 6.75 years. total yearly compensation is €1.09M, comprised of 43.1% salary and 56.9% bonuses, including company stock and options. directly owns 0.64% of the company’s shares, worth €1.35M. The average tenure of the management team and the board of directors is 5.2 years and 4.8 years respectively.
Key information
Mondher Mahjoubi
Chief executive officer
€1.1m
Total compensation
| CEO salary percentage | 43.1% |
| CEO tenure | 6.8yrs |
| CEO ownership | 0.6% |
| Management average tenure | 5.2yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -€63m |
| Mar 31 2023 | n/a | n/a | -€60m |
| Dec 31 2022 | €1m | €470k | -€58m |
| Sep 30 2022 | n/a | n/a | -€40m |
| Jun 30 2022 | n/a | n/a | -€22m |
| Mar 31 2022 | n/a | n/a | -€34m |
| Dec 31 2021 | €1m | €470k | -€45m |
| Jun 30 2021 | n/a | n/a | -€8m |
| Mar 31 2021 | n/a | n/a | -€4m |
| Dec 31 2020 | €1m | €470k | -€829k |
| Sep 30 2020 | n/a | n/a | -€54m |
| Jun 30 2020 | n/a | n/a | -€44m |
| Mar 31 2020 | n/a | n/a | -€33m |
| Dec 31 2019 | €1m | €470k | €8m |
| Sep 30 2019 | n/a | n/a | €5m |
| Jun 30 2019 | n/a | n/a | €31m |
| Mar 31 2019 | n/a | n/a | €17m |
| Dec 31 2018 | €1m | €470k | €3m |
| Sep 30 2018 | n/a | n/a | -€19m |
| Jun 30 2018 | n/a | n/a | -€40m |
| Mar 31 2018 | n/a | n/a | -€44m |
| Dec 31 2017 | €750k | €470k | -€48m |
| Sep 30 2017 | n/a | n/a | -€28m |
| Jun 30 2017 | n/a | n/a | -€8m |
| Mar 31 2017 | n/a | n/a | €3m |
| Dec 31 2016 | €2k | n/a | €13m |
Compensation vs Market: Mondher's total compensation ($USD1.17M) is above average for companies of similar size in the German market ($USD603.52K).
Compensation vs Earnings: Mondher's compensation has been consistent with company performance over the past year.
CEO
Mondher Mahjoubi (65 yo)
6.8yrs
Tenure
€1,091,442
Compensation
Dr. Mondher Mahjoubi, M.D., serves as Chairman at PDC line Pharma SAS since June 2020. He has been the Chairman of Executive Board and Chief Executive Officer of Innate Pharma S.A. since December 30, 2016....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Chairman of Supervisory Board | 24.7yrs | €100.00k | 0.92% € 1.9m | |
| Chairman of Executive Board & CEO | 6.8yrs | €1.09m | 0.64% € 1.4m | |
| Executive VP of Product Portfolio Strategy & Business Development and Member of Executive Board | 8.3yrs | €511.78k | 0.19% € 407.1k | |
| Founder | no data | no data | no data | |
| Founder | 5.7yrs | no data | 0.23% € 485.7k | |
| Founder | no data | no data | no data | |
| Founder | no data | no data | no data | |
| Founder | no data | no data | no data | |
| Senior VP & CFO | 2.4yrs | no data | 0.0012% € 2.5k | |
| Vice President of Compliance & Operations | 4.7yrs | no data | 0.050% € 106.1k | |
| Vice President of Investor Relations & Communication | less than a year | no data | 0.0012% € 2.5k | |
| VP of Legal & Corporate Affairs and Secretary of the Supervisory Board | less than a year | no data | 0.0012% € 2.5k |
5.2yrs
Average Tenure
54.5yo
Average Age
Experienced Management: IDDA's management team is seasoned and experienced (5.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Chairman of Supervisory Board | 6.8yrs | €100.00k | 0.92% € 1.9m | |
| Member of Supervisory Board | no data | no data | no data | |
| Strategic Advisory Board Member | 4.8yrs | no data | no data | |
| Independent Member of Supervisory Board | 16.2yrs | €30.00k | 0.091% € 192.1k | |
| Independent Member of Supervisory Board | 5.8yrs | €20.00k | 0.000060% € 127.0 | |
| Independent Vice Chairman of Supervisory Board | 14.3yrs | €41.00k | 0.031% € 66.0k | |
| Independent Member of Supervisory Board | 3.3yrs | €53.67k | 0.0012% € 2.6k | |
| Chairman of Strategic Advisory Board | 4.8yrs | no data | no data | |
| Independent Member of Supervisory Board | 8.4yrs | €51.00k | 0.000010% € 21.2 | |
| Strategic Advisory Board Member | 4.8yrs | no data | no data | |
| Strategic Advisory Board Member | 4.8yrs | no data | no data | |
| Strategic Advisory Board Member | 4.8yrs | no data | no data |
4.8yrs
Average Tenure
62yo
Average Age
Experienced Board: IDDA's board of directors are considered experienced (4.8 years average tenure).